129 related articles for article (PubMed ID: 26097585)
1. A novel method to identify and isolate proliferative inflammatory atrophy (PIA) clusters and to extract high-quality PIA RNA.
Wang Y; Hao C; Fu B; Liu W; Zhou X; Zeng T; Guo J; Wang G
Int J Clin Exp Pathol; 2015; 8(4):3987-93. PubMed ID: 26097585
[TBL] [Abstract][Full Text] [Related]
2. Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate.
Wang W; Bergh A; Damber JE
Prostate; 2009 Sep; 69(13):1378-86. PubMed ID: 19507201
[TBL] [Abstract][Full Text] [Related]
3. Increased p53 immunoreactivity in proliferative inflammatory atrophy of prostate is related to focal acute inflammation.
Wang W; Bergh A; Damber JE
APMIS; 2009 Mar; 117(3):185-95. PubMed ID: 19245591
[TBL] [Abstract][Full Text] [Related]
4. Topographic and quantitative relationship between prostate inflammation, proliferative inflammatory atrophy and low-grade prostate intraepithelial neoplasia: a biopsy study in chronic prostatitis patients.
Vral A; Magri V; Montanari E; Gazzano G; Gourvas V; Marras E; Perletti G
Int J Oncol; 2012 Dec; 41(6):1950-8. PubMed ID: 23026863
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic utility of novel immunohistochemical marker ERG in the workup of prostate biopsies with "atypical glands suspicious for cancer".
He H; Magi-Galluzzi C; Li J; Carver P; Falzarano S; Smith K; Rubin MA; Zhou M
Am J Surg Pathol; 2011 Apr; 35(4):608-14. PubMed ID: 21383613
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of proliferative inflammatory atrophy finding in prostatic biopsies.
Servian P; Celma A; Planas J; Placer J; de Torres IM; Olivan M; Morote J
Prostate; 2015 Oct; 75(14):1669-75. PubMed ID: 26184870
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome is not associated with greater evidences of proliferative inflammatory atrophy and inflammation in patients with suspected prostate cancer.
Russo GI; Cimino S; Giranio G; Regis F; Favilla V; Privitera S; Motta F; Caltabiano R; Stenzl A; Todenhöfer T; Morgia G
Urol Oncol; 2018 May; 36(5):240.e21-240.e26. PubMed ID: 29429896
[TBL] [Abstract][Full Text] [Related]
8. IL-17 Expression by macrophages is associated with proliferative inflammatory atrophy lesions in prostate cancer patients.
Vykhovanets EV; Maclennan GT; Vykhovanets OV; Gupta S
Int J Clin Exp Pathol; 2011 Aug; 4(6):552-65. PubMed ID: 21904631
[TBL] [Abstract][Full Text] [Related]
9. Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia.
Putzi MJ; De Marzo AM
Urology; 2000 Nov; 56(5):828-32. PubMed ID: 11068311
[TBL] [Abstract][Full Text] [Related]
10. Proliferative inflammatory atrophy: a background lesion of prostate cancer?
Woenckhaus J; Fenic I
Andrologia; 2008 Apr; 40(2):134-7. PubMed ID: 18336466
[TBL] [Abstract][Full Text] [Related]
11. Preneoplastic prostate lesions: an opportunity for prostate cancer prevention.
Nelson WG; De Marzo AM; Deweese TL; Lin X; Brooks JD; Putzi MJ; Nelson CP; Groopman JD; Kensler TW
Ann N Y Acad Sci; 2001 Dec; 952():135-44. PubMed ID: 11795433
[TBL] [Abstract][Full Text] [Related]
12. Atrophy in specimens of radical prostatectomy: is there topographic relation to high-grade prostatic intraepithelial neoplasia or cancer?
Brasil AA; Favaro WJ; Cagnon VH; Ferreira U; Billis A
Int Urol Nephrol; 2011 Jun; 43(2):397-403. PubMed ID: 20632094
[TBL] [Abstract][Full Text] [Related]
13. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.
Bethel CR; Faith D; Li X; Guan B; Hicks JL; Lan F; Jenkins RB; Bieberich CJ; De Marzo AM
Cancer Res; 2006 Nov; 66(22):10683-90. PubMed ID: 17108105
[TBL] [Abstract][Full Text] [Related]
14. Quantitative immunohistochemical detection of the molecular expression patterns in proliferative inflammatory atrophy.
Karaivanov M; Todorova K; Kuzmanov A; Hayrabedyan S
J Mol Histol; 2007 Mar; 38(1):1-11. PubMed ID: 17171435
[TBL] [Abstract][Full Text] [Related]
15. HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer.
Montironi R; Mazzucchelli R; Barbisan F; Stramazzotti D; Santinelli A; Scarpelli M; Lòpez Beltran A
Hum Pathol; 2006 Sep; 37(9):1137-44. PubMed ID: 16938518
[TBL] [Abstract][Full Text] [Related]
16. Human prostate cancer precursors and pathobiology.
De Marzo AM; Meeker AK; Zha S; Luo J; Nakayama M; Platz EA; Isaacs WB; Nelson WG
Urology; 2003 Nov; 62(5 Suppl 1):55-62. PubMed ID: 14607218
[TBL] [Abstract][Full Text] [Related]
17. TNFα-mediated loss of β-catenin/E-cadherin association and subsequent increase in cell migration is partially restored by NKX3.1 expression in prostate cells.
Debelec-Butuner B; Alapinar C; Ertunc N; Gonen-Korkmaz C; Yörükoğlu K; Korkmaz KS
PLoS One; 2014; 9(10):e109868. PubMed ID: 25360740
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of ELAV-like protein HuR is associated with increased COX-2 expression in atrophy, high-grade prostatic intraepithelial neoplasia, and incidental prostate cancer in cystoprostatectomies.
Barbisan F; Mazzucchelli R; Santinelli A; Lopez-Beltran A; Cheng L; Scarpelli M; Montorsi F; Montironi R
Eur Urol; 2009 Jul; 56(1):105-12. PubMed ID: 18468781
[TBL] [Abstract][Full Text] [Related]
19. Significance of focal proliferative atrophy lesions in prostate biopsy cores that test negative for prostate carcinoma.
Asimakopoulos AD; Miano R; Mauriello A; Costantini S; Pasqualetti P; Liberati E; Finazzi Agrò E; Germani S; Virgili G; Vespasiani G
Urol Oncol; 2011; 29(6):690-7. PubMed ID: 20451420
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of proliferative inflammatory atrophy in prostate biopsy.
Celma A; Servián P; Planas J; Placer J; Quilez MT; Arbós MA; de Torres I; Morote J
Actas Urol Esp; 2014 Mar; 38(2):122-6. PubMed ID: 24129226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
